Cargando…

Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study

INTRODUCTION: Breast development and hormonal changes at puberty might affect breast cancer risk, but epidemiological analyses have focussed largely on age at menarche and not at other pubertal stages. METHODS: We investigated associations between the timing of pubertal stages and breast cancer risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodicoat, Danielle H, Schoemaker, Minouk J, Jones, Michael E, McFadden, Emily, Griffin, James, Ashworth, Alan, Swerdlow, Anthony J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978643/
https://www.ncbi.nlm.nih.gov/pubmed/24495528
http://dx.doi.org/10.1186/bcr3613
_version_ 1782310605642792960
author Bodicoat, Danielle H
Schoemaker, Minouk J
Jones, Michael E
McFadden, Emily
Griffin, James
Ashworth, Alan
Swerdlow, Anthony J
author_facet Bodicoat, Danielle H
Schoemaker, Minouk J
Jones, Michael E
McFadden, Emily
Griffin, James
Ashworth, Alan
Swerdlow, Anthony J
author_sort Bodicoat, Danielle H
collection PubMed
description INTRODUCTION: Breast development and hormonal changes at puberty might affect breast cancer risk, but epidemiological analyses have focussed largely on age at menarche and not at other pubertal stages. METHODS: We investigated associations between the timing of pubertal stages and breast cancer risk using data from a cohort study of 104,931 women (Breakthrough Generations Study, UK, 2003–2013). Pubertal variables were reported retrospectively at baseline. Breast cancer risk was analysed using Cox regression models with breast cancer diagnosis as the outcome of interest, attained age as the underlying time variable, and adjustment for potentially confounding variables. RESULTS: During follow-up (mean = 4.1 years), 1094 breast cancers (including ductal carcinoma in situ) occurred. An increased breast cancer risk was associated with earlier thelarche (age when breast growth begins; HR [95% CI] = 1.23 [1.02, 1.48], 1 [referent] and 0.80 [0.69, 0.93] for ≤10, 11–12 and ≥13 years respectively), menarche (initiation of menses; 1.06 [0.93, 1.21], 1 [referent] and 0.78 [0.62, 0.99] for ≤12, 13–14 and ≥15 years), regular periods (0.99 [0.83, 1.18], 1 [referent] and 0.74 [0.59, 0.92] for ≤12, 13–14 and ≥15 years) and age reached adult height (1.25 [1.03, 1.52], 1 [referent] and 1.07 [0.87, 1.32] for ≤14, 15–16 and ≥17 years), and with increased time between thelarche and menarche (0.87 [0.65, 1.15], 1 [referent], 1.14 [0.96, 1.34] and 1.27 [1.04, 1.55] for <0, 0, 1 and ≥2 years), and shorter time between menarche and regular periods (1 [referent], 0.87 [0.73, 1.04] and 0.66 [0.50, 0.88] for 0, 1 and ≥2 years). These associations were generally similar when considered separately for premenopausal and postmenopausal breast cancer. CONCLUSIONS: Breast duct development may be a time of heightened susceptibility to risk of carcinogenesis, and greater attention needs to be given to the relation of breast cancer risk to the different stages of puberty.
format Online
Article
Text
id pubmed-3978643
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39786432014-04-08 Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study Bodicoat, Danielle H Schoemaker, Minouk J Jones, Michael E McFadden, Emily Griffin, James Ashworth, Alan Swerdlow, Anthony J Breast Cancer Res Research Article INTRODUCTION: Breast development and hormonal changes at puberty might affect breast cancer risk, but epidemiological analyses have focussed largely on age at menarche and not at other pubertal stages. METHODS: We investigated associations between the timing of pubertal stages and breast cancer risk using data from a cohort study of 104,931 women (Breakthrough Generations Study, UK, 2003–2013). Pubertal variables were reported retrospectively at baseline. Breast cancer risk was analysed using Cox regression models with breast cancer diagnosis as the outcome of interest, attained age as the underlying time variable, and adjustment for potentially confounding variables. RESULTS: During follow-up (mean = 4.1 years), 1094 breast cancers (including ductal carcinoma in situ) occurred. An increased breast cancer risk was associated with earlier thelarche (age when breast growth begins; HR [95% CI] = 1.23 [1.02, 1.48], 1 [referent] and 0.80 [0.69, 0.93] for ≤10, 11–12 and ≥13 years respectively), menarche (initiation of menses; 1.06 [0.93, 1.21], 1 [referent] and 0.78 [0.62, 0.99] for ≤12, 13–14 and ≥15 years), regular periods (0.99 [0.83, 1.18], 1 [referent] and 0.74 [0.59, 0.92] for ≤12, 13–14 and ≥15 years) and age reached adult height (1.25 [1.03, 1.52], 1 [referent] and 1.07 [0.87, 1.32] for ≤14, 15–16 and ≥17 years), and with increased time between thelarche and menarche (0.87 [0.65, 1.15], 1 [referent], 1.14 [0.96, 1.34] and 1.27 [1.04, 1.55] for <0, 0, 1 and ≥2 years), and shorter time between menarche and regular periods (1 [referent], 0.87 [0.73, 1.04] and 0.66 [0.50, 0.88] for 0, 1 and ≥2 years). These associations were generally similar when considered separately for premenopausal and postmenopausal breast cancer. CONCLUSIONS: Breast duct development may be a time of heightened susceptibility to risk of carcinogenesis, and greater attention needs to be given to the relation of breast cancer risk to the different stages of puberty. BioMed Central 2014 2014-02-04 /pmc/articles/PMC3978643/ /pubmed/24495528 http://dx.doi.org/10.1186/bcr3613 Text en Copyright © 2014 Bodicoat et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bodicoat, Danielle H
Schoemaker, Minouk J
Jones, Michael E
McFadden, Emily
Griffin, James
Ashworth, Alan
Swerdlow, Anthony J
Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
title Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
title_full Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
title_fullStr Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
title_full_unstemmed Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
title_short Timing of pubertal stages and breast cancer risk: the Breakthrough Generations Study
title_sort timing of pubertal stages and breast cancer risk: the breakthrough generations study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978643/
https://www.ncbi.nlm.nih.gov/pubmed/24495528
http://dx.doi.org/10.1186/bcr3613
work_keys_str_mv AT bodicoatdanielleh timingofpubertalstagesandbreastcancerriskthebreakthroughgenerationsstudy
AT schoemakerminoukj timingofpubertalstagesandbreastcancerriskthebreakthroughgenerationsstudy
AT jonesmichaele timingofpubertalstagesandbreastcancerriskthebreakthroughgenerationsstudy
AT mcfaddenemily timingofpubertalstagesandbreastcancerriskthebreakthroughgenerationsstudy
AT griffinjames timingofpubertalstagesandbreastcancerriskthebreakthroughgenerationsstudy
AT ashworthalan timingofpubertalstagesandbreastcancerriskthebreakthroughgenerationsstudy
AT swerdlowanthonyj timingofpubertalstagesandbreastcancerriskthebreakthroughgenerationsstudy